Explore the Blog

Explore the collective stream of consciousness of FDA regulation of drugs, biologics, and devices at the Regulationships blog.

And no, Regulationships is not a place to find dates with all those really awesome regulatory, compliance, or legal people you know. As glamourous, stylish, dynamic and attractive as most are, you'll still have to go somewhere else if you're looking for that kind of companionship.

Links

Grayscale Compliance
Good Reprint Practices
PharmaMarketing Blog
Eye On FDA
Bioethic.net
Public Citizen
FDA
FDA Warning Letters
DDMAC (Drugs)
APLB (Biologics)
FDA REMS Page
Department of Justice
Pharmalot
Wall Street Journal Health Blog
Bnet Pharma

Regulationships.com has been created and authored by John Murray, a regulatory and compliance consultant to industry (that's me). I've spent my entire professional career working for drug and biologic manufacturers, mostly regulating advertising, promotion, and labeling for FDA-regulated products. I've also managed compliance operations for a multi billion dollar companies and have spent a lot of time negotiating with and making submissions to FDA over a variety of regulatory issues. Unfortunately, some of these have been related to enforcement actions, but most often negotiations have been collaborative as part of things like labeling negotiations, advisory comment negotiations, and a variety of meeting purposes (something I seem to be doing even more frequently now, as a consultant).

Since 2008, I've worked as an Consultant to many companies in industry helping with compliance, advertising and promotion, training and a variety of other issues. Through my company Grayscale Compliance, LLC. I get paid by drug manufacturers to help their business stay compliant with regulations and to strategically anticipate and address potential issues. In an ideal world, the entire industry would be my customer. So take anything I say on this website with that knowledge. I don't mind the criticism of this website content for this potential source of bias, if it comes to that. But be reminded, for any blogger, critic, or interested person, the fact that they have potential sources of bias does not discredit thoughtful and truthful discussion. Nonetheless, disclosure and transparency is good, within reason and where necessary (it's necessary here). A world without disclosure and transparency is not a place for me.

I am also creator, author and co-founder of GoodReprintPractices.com a site dedicated to expert commentary on FDA regulation of scientific communications.

Please feel free to contact me for any reason at any time using the contact function in the menu (unless you're a spammer of course). Also, if you'd like to contribute to this site just contact me. I welcome contributions to keep things lively and ongoing (dead sites are a drag).

• Home > 
• About  >